NuCana (NCNA) Non-cash Items (2017 - 2025)
NuCana (NCNA) reported Non-cash Items of -$2.5 million for Q4 2025, down 44.07% on a YoY basis from -$4.4 million in Q4 2024, and down 44.07% sequentially from -$1.7 million in Q4 2024.
NuCana (NCNA) Non-cash Items (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 7 years of Non-cash Items data on file, last reported at -$2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non-cash Items fell 44.07% year-over-year to -$2.5 million; the trailing twelve-month figure through Dec 2025 stood at -$19.5 million (up 26.86% YoY), and the FY2025 full-year result was -$10.3 million, up 61.68% from the prior year.
- Non-cash Items eased to -$2.5 million in Q4 2025, from -$1.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of -$1.7 million in Q4 2024 to a low of -$13.7 million in Q3 2023.
- A 5-year average of -$8.4 million and a median of -$8.9 million in 2023 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items soared 80.67% in 2024 and plunged 44.07% in 2025, its largest moves.
- Tracing NCNA's Non-cash Items over 5 years: stood at -$12.1 million in 2021, then fell by 8.83% to -$13.2 million in 2022, then surged by 32.73% to -$8.9 million in 2023, then soared by 80.67% to -$1.7 million in 2024, then plunged by 44.07% to -$2.5 million in 2025.
- Business Quant data shows NCNA's Non-cash Items at -$2.5 million in Q4 2025, -$1.7 million in Q4 2024, and -$5.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.47 Mn |
| Dec 31, 2025 | -2.47 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Mar 31, 2024 | -9.64 Mn |
| Mar 31, 2024 | -9.64 Mn |
| Dec 31, 2023 | -8.88 Mn |
| Dec 31, 2023 | -8.88 Mn |
| Sep 30, 2023 | -13.74 Mn |
| Sep 30, 2023 | -13.74 Mn |
| Jun 30, 2023 | -6.96 Mn |
| Jun 30, 2023 | -6.96 Mn |
| Mar 31, 2023 | -8.73 Mn |
| Mar 31, 2023 | -8.73 Mn |
| Mar 31, 2022 | -13.21 Mn |
| Mar 31, 2022 | -13.21 Mn |